In order to study the role of PTK7 in motility and invasivity of TNBC cells, dominant-negative inhibition of PTK7 through overexpression of a kinase domain deletion mutant (PTK7DN) in the highly invasive, PTK7-expressing BC cell line Hs578T was applied (Figure 3A). This evidence concerns the gene PTK7 and breast cancer.